Prevest Denpro Ltd

Prevest Denpro Ltd has announced the closure of its trading window for all directors, promoters, designated employees, connected persons, and their immediate relatives. This closure is effective from Thursday, October 01, 2026, and is in preparation for the declaration of the company's unaudited financial results for the quarter and half-year ending September 30, 2026. The trading window is set to reopen 48 hours after the official announcement of these financial results to the stock exchange. This measure is a standard corporate governance practice to prevent insider trading.

Prevest Denpro Ltd has issued letters to shareholders whose email addresses are not registered with the RTA or company. These letters provide a weblink to access the AGM Notice and Integrated Annual Report for FY 2025-26, in compliance with SEBI Listing Regulations. The 27th Annual General Meeting is scheduled for September 17, 2026, via Video Conferencing. Electronic voting will be open from September 14 to September 16, 2026.

Prevest Denpro Ltd has submitted its Annual Report for the Financial Year 2025-26, in compliance with SEBI regulations. The report includes the Notice of the 27th Annual General Meeting (AGM) scheduled for September 17, 2026, to be held via Video Conferencing. The Annual Report details the company's performance, financial highlights, R&D initiatives, global footprint, CSR activities, and future vision. It also contains standalone and consolidated financial statements, auditor's reports, and the Board's report. The company emphasizes its commitment to innovation, quality, and advancing dental healthcare, contributing to India's growth in the healthcare sector.

Prevest Denpro Ltd has announced that its 27th Annual General Meeting (AGM) will be held on Thursday, September 17, 2026, at 12:30 p.m. IST. The meeting will be conducted through Video Conferencing/Other Audio Visual Means (VC/OAVM). Key agenda items include the adoption of audited standalone and consolidated financial statements for FY 2025-26, declaration of a final dividend of ₹1 per equity share, re-appointment of a director retiring by rotation, appointment of statutory auditors M/s. A D V & Associates for five years, and ratification of remuneration for cost auditors M/s. PAN & Associates for FY 2025-26 and 2026-27. The re-appointment of Mrs. Namrata Modi as Whole-Time Director is also on the agenda.

Prevest Denpro Limited announced its financial results for the quarter ended June 30, 2026, reporting significant year-on-year growth. Consolidated Revenue from Operations increased by 20.94% to ₹1,906.83 lakh, while Consolidated Profit After Tax (PAT) rose by 27.99% to ₹563.86 lakh. Standalone Revenue from Operations grew 23.66% YoY to ₹1,944.33 lakh, and Standalone PAT increased by 24.77% YoY to ₹578.23 lakh. The company's Board of Directors also recommended a dividend of 10%, or ₹1 per equity share, for FY 2025-26, subject to shareholder approval. The strong performance was attributed to sustained demand, business momentum, and operational efficiency.

Prevest Denpro Ltd has announced that the Board of Directors has fixed Saturday, September 05, 2026, as the record date for the payment of the final dividend for the Financial Year 2025-26. This dividend is subject to declaration at the company's 27th Annual General Meeting. The company has requested this information be taken on record.

Prevest Denpro Ltd announced that its Board of Directors, in a meeting held on August 11, 2026, considered and approved the unaudited financial results for the quarter ended June 30, 2026. The results were prepared on a standalone and consolidated basis and were accompanied by a Limited Review Report. Additionally, the Board recommended a final dividend of 10% (₹1.00 per equity share) for the financial year ended March 31, 2026, subject to shareholder approval at the upcoming Annual General Meeting. The company also informed about the notice of its 27th AGM, Directors' Report, and Management Discussion and Analysis Report.

Prevest Denpro Ltd announced that its Board of Directors, in a meeting held on August 11, 2026, approved the unaudited financial results for the quarter ended June 30, 2026 (Q1 FY27), both on a standalone and consolidated basis. The Board also recommended a final dividend of 10% (Rs. 1.00 per equity share) for the Financial Year ended March 31, 2026, subject to shareholder approval. Additionally, the company will proceed with its 27th Annual General Meeting, along with the Directors' Report and Management Discussion and Analysis Report for FY26.

Prevest Denpro Ltd has announced that its Board of Directors will convene on August 11, 2026. The primary agenda items include the consideration and approval of the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026 (Q1 FY27). Additionally, the board will discuss and recommend the Final Dividend for the Financial Year 2025-26. This meeting is being held in compliance with SEBI's Listing Obligations and Disclosure Requirements.

Prevest Denpro Ltd has announced the closure of its trading window for all directors, promoters, designated employees, connected persons, and their immediate relatives. This closure is effective from Wednesday, July 01, 2026, and is in connection with the upcoming declaration of the company's unaudited financial results for the quarter ending June 30, 2026. The trading window is set to reopen 48 hours after the financial results are officially declared to the stock exchange.